Company: WHWK
Filing Date: 2025-01-21
Form Type: PREM14A
Source: 0001193125-25-009599
Chunk: 97

Company: Whitehawk Therapeutics, Inc.
Filing Date: 2025-01-21
Form: PREM14A
Chunk 97
---
 | Aadi’s potential liability under the Divestiture Agreement for indemnification payments and purchase price 
 adjustments;                                                                                               |

| • |     | the potential interests of Aadi’s officers and directors in the Divestiture that may be different from, or 
 in addition to, the interests of Aadi stockholders generally;                                              |

| • |     | the risk that Aadi may be the subject of legal proceedings relating to the Divestiture which may have the effect 
 of delaying, enjoining or preventing the Divestiture or requiring the payment of damages;                        |

| • |     | the risk of Aadi incurring substantial expenses related to the Divestiture, including in connection with any                                             
 litigation that may result from the announcement or pendency of the Divestiture, some of which will be payable even if the Divestiture is not completed; |

| • |     | the fact that a failure to complete the Divestiture may negatively impact Aadi’s relationships with its 
 employees, suppliers and customers;                                                                     |

| • |     | the fact that, while Aadi expects that the Divestiture will be completed, there can be no assurance that all                                    
 conditions to the parties’ obligations to complete the Divestiture will be satisfied, and, as a result, the Divestiture may not be consummated; |

| • |     | the effects that a failure to consummate the Divestiture could have on the price of Aadi’s common stock and 
 on the market’s perceptions of Aadi’s prospects; and                                                        |

| • |     | various other risks associated with the Divestiture and Aadi’s business, as more fully described in the 
 section entitled “Special Note Regarding Forward-Looking Statements.”                                   |

The foregoing discussion of the factors considered by Aadi’s board of directors is not intended to be exhaustive, but does set forth the material factors considered by Aadi’s board of directors. Aadi’s board of directors reached the unanimous conclusion to approve the Divestiture Agreement in light of the various factors described above and other factors that each member of Aadi’s board of directors felt were appropriate. In view of the wide variety of factors considered by Aadi’s board of directors in connection with its evaluation of the Divestiture and the complexity of these matters, Aadi’s board of directors did not consider it practical, and did not attempt to quantify, rank or otherwise assign relative weights to the specific factors it considered in reaching its decision and did not undertake